Trial Profile
PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 29 Nov 2023
Price :
$35
*
At a glance
- Drugs PG 2 (Primary)
- Indications Fatigue
- Focus Therapeutic Use
- Sponsors PhytoHealth
- 15 Sep 2014 New trial record